======= DPH2 =======
== Gene Information ==
* **Official Symbol**: DPH2
* **Official Name**: diphthamide biosynthesis 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1802|1802]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BQC3|Q9BQC3]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=DPH2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DPH2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/603456|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Required for the first step in the synthesis of diphthamide, a post-translational modification of histidine which occurs in translation elongation factor 2 (EEF2). {ECO:0000250|UniProtKB:Q9CR25}.
|Diphthamide syn|
|2-(3-amino-3-carboxypropyl)histidine synthase activity|
|peptidyl-diphthamide biosynthetic process from peptidyl-histidine|
|peptidyl-diphthamide metabolic process|
|regulation of cytoplasmic translational elongation|
|peptidyl-histidine modification|
|regulation of translational elongation|
|regulation of cytoplasmic translation|
|regulation of translation|
|regulation of cellular amide metabolic process|
|posttranscriptional regulation of gene expression|
|peptidyl-amino acid modification|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-2.84|
|[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-2.69|
|[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-2.51|
|[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-2.5|
|[[:results:exp510|Nicotine 3000μM R08 exp510]]|-2.42|
|[[:results:exp460|BML-284 0.09μM R08 exp460]]|-2.11|
|[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|-2.08|
|[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-1.91|
|[[:results:exp19|Etoposide 1μM R00 exp19]]|-1.84|
|[[:results:exp176|Apcin 50 to 100μM on day4 R04 exp176]]|-1.82|
|[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-1.82|
|[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-1.79|
|[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-1.75|
|[[:results:exp31|Rifampicin 1μM R00 exp31]]|-1.74|
|[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|1.7|
|[[:results:exp84|UM0125461 0.74μM R02 exp84]]|1.77|
|[[:results:exp359|FK-506 30μM R07 exp359]]|1.83|
|[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|1.89|
|[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|2.51|
|[[:results:exp275|Citral 75μM R06 exp275]]|2.76|
|[[:results:exp274|Citral 50μM R06 exp274]]|2.99|
|[[:results:exp85|UM0129480 7μM R02 exp85]]|3.47|
^Gene^Correlation^
|[[:human genes:d:dph1|DPH1]]|0.726|
|[[:human genes:d:dnajc24|DNAJC24]]|0.69|
|[[:human genes:d:dph5|DPH5]]|0.685|
|[[:human genes:d:dph6|DPH6]]|0.546|
|[[:human genes:d:dph3|DPH3]]|0.483|
|[[:human genes:e:elp6|ELP6]]|0.419|
|[[:human genes:a:aar2|AAR2]]|0.409|
Global Fraction of Cell Lines Where Essential: 2/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|1/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|1/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4233
* **Expression level (log2 read counts)**: 6.2
{{:chemogenomics:nalm6 dist.png?nolink |}}